METASTATIC LIVER CANCER
Clinical trials for METASTATIC LIVER CANCER explained in plain language.
Never miss a new study
Get alerted when new METASTATIC LIVER CANCER trials appear
Sign up with your email to follow new studies for METASTATIC LIVER CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Engineered immune cells take on tough liver cancer
Disease control Recruiting nowThis study tests a new treatment for adults with advanced liver cancer that has stopped responding to standard therapies. The treatment uses specially engineered immune cells (CAR-NK cells) from a healthy donor that are designed to target and kill cancer cells. The study will fir…
Matched conditions: METASTATIC LIVER CANCER
Phase: PHASE1, PHASE2 • Sponsor: Beijing Biotech • Aim: Disease control
Last updated May 22, 2026 14:04 UTC
-
New hope for advanced liver cancer: targeted radiation therapy trial launches
Disease control Recruiting nowThis study tests a drug called 177Lu-PSMA-617 in people with liver cancer that has spread and shows a specific marker (PSMA) on scans. The drug delivers radiation directly to cancer cells. The trial aims to see if this approach is safe and can help control the disease. About 10 a…
Matched conditions: METASTATIC LIVER CANCER
Phase: PHASE2 • Sponsor: Melissa Lumish • Aim: Disease control
Last updated May 19, 2026 11:48 UTC
-
New T-Cell therapy targets tough liver cancers
Disease control Recruiting nowThis study tests a new treatment called ECT204 for adults with advanced liver cancer that has not responded to at least two prior therapies. The treatment uses specially engineered immune cells to attack cancer cells. The goal is to check safety and find the best dose, with early…
Matched conditions: METASTATIC LIVER CANCER
Phase: PHASE1, PHASE2 • Sponsor: Eureka Therapeutics Inc. • Aim: Disease control
Last updated May 19, 2026 11:46 UTC
-
New hope for advanced cancers: first human trial of ERX-315 begins
Disease control Recruiting nowThis early-stage study tests a new drug called ERX-315 in people with advanced solid tumors (like breast, ovarian, or pancreatic cancer) that no longer respond to standard treatments. The main goal is to check the drug's safety and find the best dose for future studies. About 15 …
Matched conditions: METASTATIC LIVER CANCER
Phase: PHASE1 • Sponsor: EtiraRx Australia Pty Ltd • Aim: Disease control
Last updated May 18, 2026 12:03 UTC